dc.contributor
Institut Català de la Salut
dc.contributor
[Smit M] Expertise Centre Movement Disorders Groningen, Department of Neurology, University Medical Centre Groningen, Groningen, Netherlands. [Albanese A] Department of Neurology, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Milan, Italy. [Benson M] Dystonia Europe, Brussels, Belgium. [Edwards MJ] Neuroscience Research Centre, Institute of Molecular and Clinical Sciences, St George's University of London, London, United Kingdom. [Graessner H] Institute of Medical Genetics and Applied Genomics and Centre for Rare Diseases, University of Tübingen, Tübingen, Germany. [Hutchinson M] Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland. [Pérez Dueñas B] Grup de Recerca en Neurologia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Smit, Marenka
dc.contributor.author
Albanese, Alberto
dc.contributor.author
Benson, Monika
dc.contributor.author
Edwards, Mark J.
dc.contributor.author
Graessner, Holm
dc.contributor.author
Hutchinson, Michael
dc.contributor.author
Perez Dueñas, Belen
dc.date.accessioned
2023-11-08T15:22:41Z
dc.date.available
2023-11-08T15:22:41Z
dc.date.issued
2022-03-21T08:53:20Z
dc.date.issued
2022-03-21T08:53:20Z
dc.identifier
Smit M, Albanese A, Benson M, Edwards MJ, Graessner H, Hutchinson M, et al. Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe. Front Neurol. 2021 Jun;12:646841.
dc.identifier
https://hdl.handle.net/11351/7212
dc.identifier
10.3389/fneur.2021.646841
dc.identifier
000662183800001
dc.identifier.uri
https://hdl.handle.net/11351/7212
dc.description.abstract
DystoniaNet; Xarxa europea; Distonia
dc.description.abstract
DytoniaNet; Red europea; Distonía
dc.description.abstract
DystoniaNet; European network; Dystonia
dc.description.abstract
Improved care for people with dystonia presents a number of challenges. Major gaps in knowledge exist with regard to how to optimize the diagnostic process, how to leverage discoveries in pathophysiology into biomarkers, and how to develop an evidence base for current and novel treatments. These challenges are made greater by the realization of the wide spectrum of symptoms and difficulties faced by people with dystonia, which go well-beyond motor symptoms. A network of clinicians, scientists, and patients could provide resources to facilitate information exchange at different levels, share mutual experiences, and support each other's innovative projects. In the past, collaborative initiatives have been launched, including the American Dystonia Coalition, the European Cooperation in Science and Technology (COST—which however only existed for a limited time), and the Dutch DystonieNet project. The European Reference Network on Rare Neurological Diseases includes dystonia among other rare conditions affecting the central nervous system in a dedicated stream. Currently, we aim to broaden the scope of these initiatives to a comprehensive European level by further expanding the DystoniaNet network, in close collaboration with the ERN-RND. In line with the ERN-RND, the mission of DystoniaNet Europe is to improve care and quality of life for people with dystonia by, among other endeavors, facilitating access to specialized care, overcoming the disparity in education of medical professionals, and serving as a solid platform to foster international clinical and research collaborations. In this review, both professionals within the dystonia field and patients and caregivers representing Dystonia Europe highlight important unsolved issues and promising new strategies and the role that a European network can play in activating them.
dc.format
application/pdf
dc.publisher
Frontiers Media
dc.relation
Frontiers in Neurology;12
dc.relation
https://doi.org/10.3389/fneur.2021.646841
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Distonia - Diagnòstic
dc.subject
Qualitat de vida - Avaluació
dc.subject
Malalties rares
dc.subject
DISEASES::Nervous System Diseases::Neurologic Manifestations::Dyskinesias::Dystonia
dc.subject
Other subheadings::Other subheadings::/diagnosis
dc.subject
HEALTH CARE::Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life
dc.subject
DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Rare Diseases
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::manifestaciones neurológicas::discinesias::distonía
dc.subject
Otros calificadores::Otros calificadores::/diagnóstico
dc.subject
ATENCIÓN DE SALUD::ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida
dc.subject
ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::enfermedades raras
dc.title
Dystonia Management: What to Expect From the Future? The Perspectives of Patients and Clinicians Within DystoniaNet Europe
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion